Buscar resultados de ensayos clínicos
Pustular Psoriasis - 29 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis Condición: Pustulosis of Palms and Soles Fecha: 2010-09-08 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients Condición: Psoriasis Fecha: 2017-04-26 Intervenciones:
|
Completed |
Nombre del estudio: A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis Condición: Palmoplantaris Pustulosis Fecha: 2013-04-30 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis Condición: Psoriasis Fecha: 2010-11-16 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Palmoplantar Pustular Psoriasis Efficacy and Safety wIth Secukinumab Condición: Palmoplantar Pustular Psoriasis Fecha: 2013-12-08 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis Condición: Pustular Psoriasis Fecha: 2015-01-16 Intervenciones: Drug: Guselkumab Participants will receive 50 milligram (mg) guselkumab subcutaneously at Weeks 0, 4 and |
Active, not recruiting |
Nombre del estudio: Palmoplantar Pustular Psoriasis Efficacy and Safety wIth Secukinumab Condición: Palmoplantar Pustular Psoriasis Fecha: 2013-12-08 Intervenciones:
|
Terminated |
Nombre del estudio: Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis Condición:
Fecha: 2010-03-18 Intervenciones: |
Recruiting |
Nombre del estudio: A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis Condición:
Intervenciones: Drug: risankizumab risankizumab administered by subcutaneous injection. |
Active, not recruiting |
Nombre del estudio: Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) Condición:
Intervenciones: Drug: Adalimumab Adalimumab |